Fig. 1: CD126 is ubiquitously expressed on tumor cells and is a prognostic marker. | Blood Cancer Journal

Fig. 1: CD126 is ubiquitously expressed on tumor cells and is a prognostic marker.

From: Preclinical development of CD126 CAR-T cells with broad antitumor activity

Fig. 1

a Overall survival in various types of cancer (n = 9496) based on high and low CD126 expression. Median CD126 expression (RNA-sequencing) was used to differentiate CD126 expression. b Overall survival in AML (n = 106) based on high and low CD126 expression. c MFI CD126 expression in cancer cell lines (n = 11) compared to non-cancer cell lines (n = 4). Mann–Whitney U test. **P < 0.01. Each black square is an individual data point..

Back to article page